TrialFuture oncology (London, England)2026
Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: a single-arm phase II clinical trial.
Ting Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.